For examples, abnormal phosphorylation of MEK2:S222 and ERK3:S189 was significantly correlated with survival in patients with clear cell renal cell carcinoma and lung adenocarcinoma. This evidence concerns the gene MAP2K2 and clear cell renal carcinoma.